Publications - Page 53 sur 57 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Maladies pulmonaires chroniques liées à l’environnement
[Hypersensitivity Pneumonitis: An update]

Chauvin P, Kerjouan M, Jégo P, Jouneau S, Lescoat A.

Rev Med Interne. 2021 Apr 30: S0248-8663(21)00413-6. Doi: 10.1016/j.revmed.2021.03.333
Maladies pulmonaires chroniques liées à l’environnement
[Hot tub lung: A retrospective analysis of 14 cases]

Messe R, Barrera C, Gondouin A, Dalphin JC.

Rev Mal Respir. 2021 Jan;38(1):13-21. Doi: 10.1016/j.rmr.2020.11.005.
Pneumopathies interstitielles diffuses (PID)
Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study.

Philippot Q, Kannengiesser C, Debray MP, Gauvain C, Ba I, Vieri M, Gondouin A, Naccache JM, Reynaud-Gaubert M, Uzunhan Y, Bondue B, Israël-Biet D, Dieudé P, Fourrage C, Lainey E, Manali E, Papiris S, Wemeau L, Hirschi S, Mal H, Nunes H, Schlemmer F, Blanchard E, Beier F, Cottin V, Crestani B, Borie R; OrphaLung Network.

Respirology. 2022 Jan 3.
Pneumopathies interstitielles diffuses (PID)
Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases.

Si-Mohamed SA, Nasser M, Colevray M, Nempont O, Lartaud PJ, Vlachomitrou A, Broussaud T, Ahmad K, Traclet J, Cottin V, Boussel L.

Eur Radiol. 2022 Jan 14.
Pneumopathies interstitielles diffuses (PID)
Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics.

Cottin V, Spagnolo P, Bonniaud P, Nolin M, Dalon F, Kirchgässler KU, Kamath TV, Van Ganse E, Belhassen M.

Front Med (Lausanne). 2021 Dec 24;8:802989.
Pneumopathies interstitielles diffuses (PID)
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use

Kreuter M, Maher TM, Corte TJ, Molina-Molina M, Axmann J, Gilberg F, Kirchgaessler KU, Cottin V.

Adv Ther. 2021 Dec 22.
Pneumopathies interstitielles diffuses (PID)
Comment on: Methionine supplementation; potential for improving alveolar macrophage function through reverse cholesterol transport?

Hadchouel A, Delacourt C.

Eur Respir J. 2021 Dec 2:2102937.
Pneumopathies interstitielles diffuses (PID)
Interstitial pneumonia with autoimmune features: challenges and controversies

Mackintosh JA, Wells AU, Cottin V, Nicholson AG, Renzoni EA.

Eur Respir Rev. 2021 Dec 22;30(162):210177.
Pneumopathies interstitielles diffuses (PID)
Airway complications in lung transplant recipients with telomere-related interstitial lung disease

Choi B, Messika J, Courtwright A, Mornex JF, Hirschi S, Roux A, Le Pavec J, Quêtant S, Froidure A, Lazor R, Reynaud-Gaubert M, Borgne AL, Houlbracq MP, Goldberg H, El-Chemaly S, Borie R; French Group of Lung Transplantation.

Clin Transplant. 2021 Dec 1:e14552.
Pneumopathies interstitielles diffuses (PID)
Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: a retrospective cohort

Phillips-Houlbracq M, Mal H, Cottin V, Gauvain C, Beier F, Sicre de Fontbrune F, Sidali S, Mornex JF, Hirschi S, Roux A, Weisenburger G, Roussel A, Wémeau-Stervinou L, Le Pavec J, Pison C, Marchand Adam S, Froidure A, Lazor R, Naccache JM, Jouneau S, Nunes H, Reynaud-Gaubert M, Le Borgne A, Boutboul D, Ba I, Boileau C, Crestani B, Kannengiesser C, Borie R; OrphaLung network.

Am J Transplant. 2021 Dec 1.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

[Hypersensitivity Pneumonitis: An update]

[Hot tub lung: A retrospective analysis of 14 cases]

Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study.

Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases.

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics.

Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use

Comment on: Methionine supplementation; potential for improving alveolar macrophage function through reverse cholesterol transport?

Interstitial pneumonia with autoimmune features: challenges and controversies

Airway complications in lung transplant recipients with telomere-related interstitial lung disease

Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: a retrospective cohort